Welcome to our dedicated page for Ingevity SEC filings (Ticker: NGVT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ingevity Corporation filings document formal disclosure for its specialty materials business, public-company governance, and capital structure. Form 8-K reports cover operating results, segment reporting presentation, credit agreement amendments, material agreements, and completed dispositions of North Charleston crude tall oil refinery assets and the majority of the Industrial Specialties product line.
Proxy and annual-meeting filings disclose director elections, board structure, executive compensation matters, shareholder voting results, and amendments to the company’s equity incentive plan. The filing record also includes disclosures tied to financing arrangements, continuing-operations measures, and governance matters affecting Ingevity’s common stock as a NYSE-listed issuer.
Ingevity Corporation entered into a Second Amendment and Restatement Agreement that modifies its main credit facility. The amendment extends the maturity of the company’s revolving credit facility to a date five years after March 26, 2026 and reduces total lender commitments from $1 billion to $750 million.
Borrowings will bear interest at either a term benchmark rate, with a 0.00% floor, plus a margin of 1.00% to 1.75%, or a base rate plus a margin of 0.00% to 0.75%. On the closing date, Ingevity repaid outstanding revolving loans totaling $512.1 million.
Ingevity Corp senior executive handles RSU tax obligations through share withholding. SVP, General Counsel & Secretary Ryan C. Fisher had 308 shares of common stock withheld by the company at a price of $71.78 per share to satisfy tax liabilities from 2024 RSUs that vested. After this tax-withholding disposition, he directly holds 18,194 common shares.
The Vanguard Group filed Amendment No. 13 to a Schedule 13G/A reporting no beneficial ownership of Ingevity Corp common stock. The filing states 0 shares and 0% ownership after an internal realignment that disaggregated certain subsidiaries' holdings in reliance on SEC Release No. 34-39538. The signature block shows Ashley Grim, Head of Global Fund Administration.
Ingevity Corporation’s 2026 proxy statement presents a transformed “New Ingevity” focused on two core specialty materials businesses: Performance Materials and Pavement Technologies. In 2025 the company completed a strategic portfolio review, agreed to sell its Industrial Specialties business and North Charleston crude tall oil refinery for $110 million and closed the divestiture on January 1, 2026.
For 2025, Ingevity reported $1.29 billion in revenue, a total adjusted EBITDA of $397.5 million and a total adjusted EBITDA margin of 30.8%, alongside a net loss of $(167.1) million. Free cash flow was $273.5 million and the net debt ratio improved to 2.6x, supported by six consecutive quarters of margin expansion.
The company returned $56 million to stockholders through share repurchases in 2025 and plans to generate approximately $1 billion in deployable cash over the next two years, including at least $300 million in additional repurchases, while funding organic growth and debt reduction. Stockholders are asked to elect nine directors, approve say‑on‑pay, ratify PwC as auditor, and increase authorized shares under the 2025 Omnibus Incentive Plan.
Ingevity Corp senior vice president of operations Clarence Reid Clontz Jr. reported equity compensation changes. He acquired 2,343 shares of common stock on a grant or award basis at $0.00 per share, tied to restricted stock units under the Ingevity Corporation 2025 Omnibus Incentive Plan that will vest in three equal installments on February 27, 2027, 2028, and 2029. He also had several small tax-withholding dispositions on March 2, 2026, where 143, 264, 49, and 270 shares of common stock were withheld by the company at $71.64 per share to satisfy tax obligations related to 2023, 2024, and 2025 RSUs that vested. Following these transactions, his directly owned common stock holdings were reported in the 9,000–9,700 share range after each step.
Ingevity Corp senior vice president of finance and chief accounting officer Phillip John Platt reported a mix of equity grants and tax-related share dispositions. On February 27, 2026, he acquired 2,108 restricted stock units under the 2025 Omnibus Incentive Plan, vesting in three equal installments on February 27, 2027, 2028, and 2029. On March 2, 2026, the company withheld a total of 1,070 common shares at $71.64 per share to cover tax obligations tied to vested RSUs from 2023, 2024, and 2025, reducing his directly owned common stock to 29,949 shares.
Ingevity Corp executive Ryan C. Fisher, SVP, General Counsel & Secretary, reported equity compensation activity and related tax withholding. On February 27, 2026, he acquired 4,442 shares of common stock at $0.00 per share as a grant of restricted stock units under the Ingevity Corporation 2025 Omnibus Incentive Plan, scheduled to vest in three equal installments on February 27, 2027, February 27, 2028, and February 27, 2029. On March 2, 2026, a total of 1,333 shares of common stock were disposed of in four transactions coded as tax-withholding dispositions at $71.64 per share, with footnotes stating the shares were withheld by the company to satisfy tax withholding obligations related to vested RSUs from 2023, 2024, and 2025. Following these transactions, Fisher directly owned 18,502 shares of Ingevity common stock.
Ingevity Corp senior executive Richard Allen White Jr. reported several tax-related share dispositions of common stock. On March 2, 2026, shares were withheld by the company at $71.64 per share to cover tax withholding obligations tied to restricted stock units that vested in 2023, 2024, and 2025. These were tax-withholding transactions, not open market sales, and White continues to hold a meaningful direct ownership stake after the withholdings.
Ingevity Corp executive vice president and chief financial officer Mary Dean Hall reported tax-related share dispositions on common stock. On March 2, 2026, she surrendered a total of 4,148 shares at $71.64 per share to satisfy withholding taxes on vesting RSU awards from 2023, 2024, and 2025. These are coded as “F” transactions, meaning shares were withheld by the company to cover tax obligations rather than sold in open-market trades. After these transactions, she directly holds 37,427 shares of Ingevity common stock.